HCID 9892134, compound → HCID 10186322, compound
Reaction equation
N[C:2]([C:30]1[CH:35]=[CH:34][C:33]([Cl:36])=[CH:32][CH:31]=1)([C:24]1[N:28]([CH3:29])[CH:27]=[N:26][CH:25]=1)[C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[N:9]([CH3:13])[C:8](=[O:14])[CH:7]=[C:6]2[C:15]1[CH:20]=[CH:19][CH:18]=[C:17]([O:21][CH2:22][CH3:23])[CH:16]=1.CN1C2C(=CC=CC=2)C(C2C=CC=C(CCC)C=2)=CC1=O>>[ClH:36].[Cl:36][C:33]1[CH:34]=[CH:35][C:30]([CH:2]([C:24]2[N:28]([CH3:29])[CH:27]=[N:26][CH:25]=2)[C:3]2[CH:4]=[C:5]3[C:10](=[CH:11][CH:12]=2)[N:9]([CH3:13])[C:8](=[O:14])[CH:7]=[C:6]3[C:15]2[CH:20]=[CH:19][CH:18]=[C:17]([O:21][CH2:22][CH3:23])[CH:16]=2)=[CH:31][CH:32]=1Participants
3
Procedure
6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-ethoxyphenyl)-1-methyl-2(1H)-quinolinone, 6-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-4-(3-propylphenyl)-2(1H)-quinolinone; a stereoisomeric form thereof or a pharmaceutically acceptable acid or base addition salt; and
Workup
- additiona stereoisomeric form thereof or a pharmaceutically acceptable acid or base addition salt
Sources & evidence
- ORD record
- ord-f6b8b004e2a243a48ca89cfa9cb04ac9
- Source dataset
- uspto-grants-2001_01
- Patent number
- US06169096A
Reaction notes
Loading…